Table 2 Association of CD14 rs2569190 and rs2569191 polymorphisms with susceptibility to TB.

From: Association of CD14 rs2569190 and rs2569191 polymorphisms with tuberculosis susceptibility in the Kurdish population of Iran

CD14 rs2569190

Groups

OR (95% CI)

P-value

AIC

BIC

Model

Genotype

Healthy control

TB patients

Allele

C

368 (64.0%)

276 (46.0%)

T

208 (36.0%)

330 (54.0%)

Codominant

C/C

104 (36.1%)

48 (15.8%)

1.00

< 0.0001*

752.1

769.7

C/T

160 (55.6%)

180 (59.4%)

3.54 (2.29–5.45)

T/T

24 (8.3%)

75 (24.8%)

18.58 (9.12–37.87)

Dominant

C/C

104 (36.1%)

48 (15.8%)

1.00

< 0.0001*

785.8

799.0

C/T-T/T

184 (63.9%)

255 (84.2%)

3.79 (2.46–5.82)

Recessive

C/C-C/T

264 (91.7%)

228 (75.2%)

1.00

< 0.0001*

784.7

797.9

T/T

24 (8.3%)

75 (24.8%)

5.65 (3.19–10.02)

Overdominant

C/C-T/T

128 (44.4%)

123 (40.6%)

1.00

0.34

824.0

837.2

C/T

160 (55.6%)

180 (59.4%)

1.17 (0.84–1.62)

Minor allele frequency (T)

0.36

0.54

CD14 rs2569191

Allele

G

308 (53.0%)

421 (69.0%)

A

268 (47.0%)

185 (31.0%)

Codominant

G/G

83 (28.8%)

134 (44.2%)

1.00

< 0.0001*

753.6

771.1

G/A

142 (49.3%)

153 (50.5%)

0.37 (0.25–0.57)

A/A

63 (21.9%)

16 (5.3%)

0.04 (0.02–0.09)

Dominant

G/G

83 (28.8%)

134 (44.2%)

1.00

< 0.0001*

802.8

815.9

G/A-A/A

205 (71.2%)

169 (55.8%)

0.37 (0.25–0.57)

Recessive

G/G-G/A

225 (78.1%)

287 (94.7%)

1.00

< 0.0001*

773.7

786.9

A/A

63 (21.9%)

16 (5.3%)

0.11 (0.06–0.21)

Overdominant

G/G-A/A

146 (50.7%)

150 (49.5%)

1.00

0.77

824.8

838.0

G/A

142 (49.3%)

153 (50.5%)

1.05 (0.76–1.46)

Minor allele frequency (A)

0.47

0.31

  1. CD14 cluster of differentiation 14; TB tuberculosis; OR odds ratios; CI confidence intervals; AIC Akaike information criterion; BIC Bayesian information criterion; *Statistically significant (< 0.05).